- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04249193
Pulse Oximetry Measurement and Transfusions (POMAT)
March 12, 2020 updated by: Kelley Kovatis, Christiana Care Health Services
Effect of Blood Transfusions on Intermittent Hypoxic Episodes in Very Low Birth Weight Infants
The primary purpose of this observational study was to determine if pRBC transfusions decrease the frequency of intermittent hypoxia events in very low birth weight infants (VLBW) during the first six weeks of life.
The impact on non-pRBC transfusions on the frequency of intermittent hypoxia was also assessed.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
75
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- Hospital of the University of Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19140
- Temple University Hospital
-
Philadelphia, Pennsylvania, United States, 19107
- Pennsylvania Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
No older than 1 month (Child)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Premature neonates
Description
Inclusion Criteria:
- 23+0 to 28+6 weeks gestational age at birth
Exclusion Criteria:
- Infants with life-limiting diagnoses
- Cyanotic heart disease
- In utero fetal transfusion
- Twin to twin transfusion syndrome
- Isoimmune hemolytic disease
- Severe acute hemorrhage
- Acute shock
- Sepsis with coagulopathy
- Need for perioperative transfusion
- Parents opposed to transfusion of blood
- Parents with hemoglobinopathy or congenital anemia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Transfusion
|
pRBC and non-pRBC transfusions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in number of Intermittent hypoxia
Time Frame: Change in number of intermittent hypoxia before (approximately 8 hours) and after transfusion (approximately 8 hours).
|
An intermittent hypoxemia event is defined as a fall in oxygen saturations to less than 80% for >/= 10 secs and <3 minutes with a minimal time interval of 4 seconds between events.
|
Change in number of intermittent hypoxia before (approximately 8 hours) and after transfusion (approximately 8 hours).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Hypoxia
Time Frame: 8 hours prior to transfusion and 8 hours after transfusion.
|
Percent time with oxygen saturations less than 85%, 80% and 75%.
|
8 hours prior to transfusion and 8 hours after transfusion.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kelley Z Kovatis, MD, Christiana Care Health Services, Inc
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2014
Primary Completion (Actual)
October 1, 2017
Study Completion (Actual)
October 1, 2017
Study Registration Dates
First Submitted
January 24, 2020
First Submitted That Met QC Criteria
January 29, 2020
First Posted (Actual)
January 30, 2020
Study Record Updates
Last Update Posted (Actual)
March 13, 2020
Last Update Submitted That Met QC Criteria
March 12, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DDD603862
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Transfusion
-
Wellspect HealthCareCompletedArthroplasty, Replacement, Knee | Blood Transfusion | Blood Transfusion, AutologousPoland
-
Wellspect HealthCareCompletedBlood Transfusion | Arthroplasty, Replacement, Hip | Blood Transfusion, AutologousAustria, Netherlands, Norway, Spain
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedBlood Transfusion | Orthopedic Surgery | Orthopedic Procedures | Cardiovascular Surgical Procedure | Blood Transfusion, Autologous
-
University of Colorado, DenverCompleted
-
Diskapi Teaching and Research HospitalCompleted
-
Clinic for Cardiovascular Diseases MagdalenaCompleted
-
Dartmouth-Hitchcock Medical CenterBEST research collaborativeCompletedBlood TransfusionNorway, United States, Australia, Canada, United Kingdom, Brazil
-
Perouse MedicalEclevar MedtechRecruitingChemotherapy | Blood Transfusion | Antibiotics | Parenteral Nutrition | Antiviral Drugs | Veinous | Blood Derivatives Transfusion | PMCF StudyFrance
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
Clinical Trials on Transfusion
-
National Institutes of Health Clinical Center (CC)Recruiting
-
Assistance Publique - Hôpitaux de ParisCompletedMyocardial Infarction | Anemia | Blood TransfusionSpain, France
-
Hamad Medical CorporationSidra Medical and Research Center; World Anti-Doping Agency; Anti-Doping Lab... and other collaboratorsUnknownBlood Disease | Blood Transfusion, Autologous | Blood Doping | Blood Transfusion, HomologousQatar
-
Daping Hospital and the Research Institute of Surgery...Children's Hospital of Chongqing Medical UniversityWithdrawnAnemia | Necrotizing Enterocolitis | Red Blood Cell (RBC) TransfusionChina
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | Primary Myelofibrosis | Thrombocytopenia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Venous Thromboembolism | Myelodysplastic Syndrome | B-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation Recipient | Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Chang Gung Memorial HospitalCompletedTrauma Patients Received Blood Transfusion ≥ 10 U | Trauma Patients Had Not Received Blood Transfusion ≥ 10 UTaiwan
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaboratorsRecruitingThe Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy VolunteersFrance
-
Hospital PitangueirasUnknown
-
Unity Health TorontoRecruitingCardiac Surgery | Heart | Postoperative | DisorderCanada, Russian Federation
-
Haukeland University HospitalDentsply Sirona Implants and ConsumablesCompleted